[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
February 25, 2004

Merits of Embryo Screening Debated

JAMA. 2004;291(8):927-929. doi:10.1001/jama.291.8.927

Washington, DC—When Laurie Goldberg Strongin and her husband Allen discovered that their son had a rare genetic disorder, they decided to have another child. Over 3 years and 9 rounds of in vitro fertilization, the couple spent $135 000 in the hopes of conceiving a baby who could save their first son, Henry.

Henry was born in 1995 with Fanconi anemia, a rare, almost universally fatal genetic disorder. The only hope for most patients with the condition is a matched sibling bone marrow transplant, which pushes survival rates to 90%.

First Page Preview View Large
First page PDF preview
First page PDF preview